EXOZYMES INC.

EXOZ · Nasdaq · $0B · 298 AI queries on Origin

Not investment advice. Origin reports data from public SEC filings with cryptographic provenance. No buy/sell/hold recommendations. Past performance does not indicate future results.
3
Observations
3
Chain Length
298
AI Queries

Filing Inventory

Form TypeCount
8-K16
S-1/A8
10-Q5
10-K2
DEF 14A1
S-11
S-31

Recent Filings

TypeFiledAccession
8-K2026-10-090001493152-26-046456
8-K2026-09-180001493152-26-043288
10-Q2026-08-130001493152-26-037725
8-K2026-03-310001493152-26-013733
10-K2026-03-300001493152-26-013563

Filing Signals

Extracted from 10-K filings using keyword pattern detection — zero inference cost

SignalMatches
risk factor
69
strategic event
65
ai adoption
13
platform shift
7
backlog growth
4
capex increase
2
$${latestQuote.close}
Last Close (2026-10-02)
0
Transcripts
34
Total Filings
exozymes.com
IR Domain

Try it — paste this into your AI:

Look up EXOZ using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show? Include the origin proof hash.

Works in ChatGPT, Claude, Gemini, or any AI with MCP support. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

Raw API · AI Discovery · MCP Endpoint

Origin Chain

#1 4ebdf1b8...
→
#2 d9c86a36...
→
#3 69e74329...

Observations

2026-10-11 · Chain #3 · 69e743294b8273a6... · parent: d9c86a366e98... · new_filing · template
## Data update for EXOZYMES INC.

EXOZYMES INC. ($EXOZ) data refreshed. 286 AI queries all-time. Signals: strategic event: 25 matches, risk factor: 23 matches, risk factor: 23 matches, ai adoption: 11 matches.
2026-08-24 · Chain #2 · d9c86a366e9831f1... · parent: 4ebdf1b80caa... · new_filing · claude-sonnet-4-6
## EXOZ: Price Erosion and Query Surge Diverge as Strategic Signal Noise Persists

Since initiating coverage on July 7, EXOZ has declined from $6.33 to $5.44 — a 14% drawdown in roughly four weeks — while AI query volume on Origin has nearly doubled from 131 to 242 all-time. That divergence is analytically notable: rising information demand against falling price typically indicates either unresolved uncertainty attracting scrutiny, or a growing investor base trying to size a risk they cannot yet quantify. Neither interpretation is reassuring without transcript data to ground it.
The filing signal composition has also shifted in a way that warrants attention. Total strategic event matches have declined from approximately 48 to 48 aggregate (25 + 9 + 7 + 7), while risk factor matches compressed from 32+ to 32 (23 + 5 + 4). On the surface this looks stable, but the redistribution matters: the largest single strategic event cluster dropped from a dominant concentration to 25 matches, suggesting either a revised filing or re-clustering of language. The ai_adoption signal holds steady at 11 matches — unchanged from the prior observation — which continues to raise the question of whether this reflects substantive operational integration or static disclosure language carried forward.
The transcript gap remains the central analytical problem. With zero transcripts captured across two consecutive observations and the stock now below $5.50, the next priority trigger is any 8-K, press release, or earnings call that can test whether the strategic event language in the 10-K reflects executed milestones. Watch specifically for partnership or licensing announcements that would validate the filing signal concentration.
2026-07-07 · Chain #1 · 4ebdf1b80caa5a1c... · genesis · seed · claude-sonnet-4-6
## EXOZ Initiating Coverage: Filing Signals Suggest Active Strategic Repositioning Amid Elevated Risk Profile

This is the inaugural observation on EXOZYMES INC. (EXOZ), trading at $6.33 on Nasdaq as of June 17, 2026, with a market capitalization registering below $1B. With no prior observations in this coverage thread, the baseline is being established here. Notably, the company has generated 131 all-time AI queries on Origin, indicating meaningful investor curiosity relative to its current scale — a signal worth tracking as a proxy for information demand.
The most analytically striking feature of the available data is the filing signal distribution from the latest 10-K. Strategic event signals dominate the filing, appearing across at least four distinct clusters totaling 48 matches, while risk factor signals account for at least 32 matches across three clusters. The concentration of strategic event language this heavily in a single 10-K filing suggests the company may be navigating a significant transition — potentially involving partnerships, licensing arrangements, platform pivots, or M&A activity. Separately, 11 ai_adoption matches indicate the company is at minimum referencing AI integration in its operational or competitive narrative, which warrants scrutiny for substance versus disclosure boilerplate.
The absence of captured earnings transcripts is a meaningful gap. Without management commentary to contextualize these filing signals, the risk-to-strategy ratio remains difficult to calibrate. The immediate priority for this coverage is the first available transcript capture, which should clarify whether the strategic event language reflects executed milestones or aspirational positioning. Watch for any 8-K filings, partnership announcements, or pipeline disclosures in the near term.
← All Coverage · Scan EXOZ · API Data